ADP-Producing Articles

- Posted: Apr 28, 2016
- By: Acta Poloniae
Avocledine 300 Pellets

NEW FORMULA HERBAL PELLETS DEMONSTRATE A UNIFORM AND STABLE RELEASE OF THE ACTIVE INGREDIENTS IN VITRO

Download Article +
- Posted: Apr 28, 2016
- By: Elsevier Ltd.
Avocledine 300 PelletsAlthough most studies have focused on the cholesterol-lowering activity of stigmasterol, other bioactivities have been ascribed to this plant sterol compound, one of which is a potential anti-inflammatory effect. To investigate the effects of stigmasterol, a plant sterol, on the inflammatory mediators and metalloproteinase produced by chondrocytes.

Download Article +
- Posted: Jul 25, 2016
- By: Aseman Darou Pars
Avocledine 300 - Mechanism of action

AVOCLEDINE contains combination of proven medical herbs that has more than 70% of active ingredient phytosterol with anti-inflammatory effects by inhibiting the pro-inflammatory enzymes including cyclooxygenase-2 (COX2) and nitric oxide synthase (NOS) in the articular tissues and prevent the production of prostaglandins-2 (PEG2) and nitric oxide (NO), reduces inflammation and joint pain.

Download Article +

search
latest posts
Article Summary
- NEW FORMULA HERBAL PELLETS DEMONSTRATE A UNIFORM AND STABLE RELEASE OF THE ACTIVE INGREDIENTS IN VITRO
  - Acta Poloniae
- Avocledine 300 PelletsAlthough most studies have focused on the cholesterol-lowering activity of stigmasterol, other bioactivities have been ascribed to this plant sterol compound, one of which is a potential anti-inflammatory effect. To investigate the effects of stigmasterol, a plant sterol, on the inflammatory mediators and metalloproteinase produced by chondrocytes.
  -Elsevier Ltd
- AVOCLEDINE contains combination of proven medical herbs that has more than 70% of active ingredient phytosterol with anti-inflammatory effects by inhibiting the pro-inflammatory enzymes including cyclooxygenase-2 (COX2) and nitric oxide synthase (NOS) in the articular tissues and prevent the production of prostaglandins-2 (PEG2) and nitric oxide (NO), reduces inflammation and joint pain.
  - Aseman Darou Pars
about us

Aseman Darou is the Head of Pharmaceutical holding that Darou Darman Ofogh Jam and Aseman Tejarat Hamoon are the shares outstandings of it. They have rights and represent ownership in the corporation by the Asemad Darou that holds the shares. Aseman Darou Produce Pharmaceutical products on contract manufacturing basis and specialy import sport suppliments from the US and Europe.

Producing Articles